Kobiolabs, Inc is based in South Korea. The head office is in Seoul. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on August 11, 2014. It currently has a total number of 57 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 6.84% in Q3C2025. During that time, Kobiolabs, Inc’s total assets decreased by 10.13%. The net profit margin of Kobiolabs, Inc decreased by 3.07% in 2025.
Headquarters
628, 220 Dong, Research Institute Of Bio
Seoul; Seoul;
Contact Details: Purchase the Kobiolabs, Inc report to view the information.
Website: http://kobiolabs.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service